Position in OGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,170,925
-$471,101 QoQ
Shares Held
86,479
-68.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#138
of 625 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $360,428,859 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,180 | $109,364,036 | |
| 2 | JNJ |
Johnson & Johnson
|
298,749 | $75,873,283 | |
| 3 | ABBV |
AbbVie Inc.
|
232,583 | $58,527,185 | |
| 4 | MRK |
Merck & Co., Inc.
|
299,881 | $38,534,708 | |
| 5 | AMGN |
Amgen Inc
|
62,806 | $22,743,307 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
155,936 | $19,700,953 | |
| 7 | PFE |
Pfizer Inc
|
676,905 | $16,299,872 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
252,254 | $14,534,874 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,170,925 | 86,479 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,642,026 | 274,128 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,995,977 | 278,379 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,956,320 | 276,809 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,910,911 | 300,714 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,124,803 | 142,700 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,182,273 | 146,265 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,810,732 | 146,928 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,125,493 | 150,990 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,927,366 | 155,711 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,267,530 | 157,249 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $527,171 | 30,367 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $657,845 | 31,612 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $824,211 | 35,043 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $994,475 | 35,606 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,648,597 | 155,923 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,921,670 | 86,568 | Shares | Sole | 2022-07-08 | |
| 2021-12-31 | $2,642,237 | 86,773 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,275,727 | 38,906 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,189,096 | 39,296 | Shares | Sole | 2021-07-12 | |
| No filing history on record for this holder in this stock. | ||||||